Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -20.52
- Piotroski Score 3.00
- Grade Buy
- Symbol (ADIL)
- Company Adial Pharmaceuticals, Inc.
- Price $0.97
- Changes Percentage (-0.28%)
- Change -$0
- Day Low $0.94
- Day High $0.98
- Year High $4.17
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.98
- Trailing P/E Ratio -0.25
- Forward P/E Ratio -0.25
- P/E Growth -0.25
- Net Income $-7,001,890
Income Statement
Quarterly
Annual
Latest News of ADIL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
If You Like Realty Income's Steadily Rising Dividend, You'll Love This Nearly 5%-Yielding Stock
Realty Income is a top REIT with a strong dividend track record. NNN REIT is another solid option, boasting 35 years of consecutive dividend growth due to its focused strategy and conservative financi...
By Yahoo! Finance | 1 week ago -
'I'm not looking at retirement': Adil Rashid steeled to fight on with England
England leg-spinner Rashid claimed his 200th ODI wicket, expressing a desire to continue playing despite the milestone. England faces Australia in a must-win match. Rashid's performance and longevity ...
By The Guardian | 1 week ago -
Olafur Eliasson artwork set to turn London's Piccadilly Circus into a blur
Icelandic-Danish artist Olafur Eliasson will showcase his latest work, Lifeworld, on digital billboards in Piccadilly Circus, London, in October. The artwork aims to slow down the fast-paced advertisi...
By The Guardian | 1 week ago
